Metabolic theories in ecology interpret ecological patterns at different levels through the lens of metabolism, typically applying allometric power scaling laws to describe rates of energy use. This requires a sound theory for metabolism at the individual level. Commonly used mechanistic growth models lack some potentially important aspects and fail to accurately capture a growth pattern often observed in insects. Recently, a new model (MGM-the Maintenance-Growth Model) was developed for ontogenetic and post-mature growth, based on an energy balance that expresses growth as the net result of assimilation and metabolic costs for maintenance and feeding. The most important contributions of MGM are: 1) the division of maintenance costs into a non-negotiable and a negotiable part, potentially resulting in maintenance costs that increase faster than linearly with mass and are regulated in response to food restriction; 2) differentiated energy allocation strategies between sexes and 3) explicit description of costs for finding and processing food. MGM may also account for effects of body composition and type of growth at the cellular level. The model was here calibrated and evaluated using empirical data from an experiment on house crickets growing under ad libitum conditions. The procedure involved parameter estimations from the literature and collected data, using statistical models to account for individual variation in parameter values. It was found that ingestion rate cannot be generally described by a simple allometry, here requiring a more complex description after maturity. Neither could feeding costs be related to ingestion rate in a simplistic manner. By the unusual feature of maintenance costs increasing faster than linearly with body mass, MGM could well capture the differentiated growth patterns of male and female crickets. Some other mechanistic growth models have been able to provide good predictions of insect growth during early ontogeny, but MGM may accurately describe the trajectory until terminated growth.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373858 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0309664 | PLOS |
Rev Alerg Mex
December 2024
Master's in economics, HS Pharmacoeconomic Research, Mexico City, Mexico.
JMIR Diabetes
December 2024
Department of Physical Activity for Health, School of Psychological Sciences and Health, University of Strathclyde, 16 Richmond Street, Glasgow, G1 1XQ, United Kingdom, 44 07753324172.
Background: The prevalence of type 2 diabetes in adults worldwide is increasing. Low levels of physical activity and sedentary behavior are major risk factors for developing the disease. Physical activity interventions incorporating activity trackers can reduce blood glucose levels in adults diagnosed with type 2 diabetes.
View Article and Find Full Text PDFACS Appl Mater Interfaces
January 2025
CAS Key Laboratory of Bio-inspired Materials and Interfacial Science, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, P.R. China.
Surface fogging affects the light transmittance of various transparent materials and poses potential safety hazards. Superhydrophilic TiO surfaces can effectively prevent fogging by promoting continuous water film formation; however, they often struggle to maintain stable hydrophilicity and adhesion on plastic films. Self-cleaning and antifogging coatings on plastic substrates are crucial for applications requiring long-term clarity and minimal maintenance costs.
View Article and Find Full Text PDFBackground: Patient navigation is an evidence-based intervention for reducing delays in cancer care for underserved populations. There are limited economic evaluations of patient navigation in the US health care system and few have considered costs at various phases along the implementation spectrum. Having economic data, including costs and cost savings, can support sustainability of patient navigation programs.
View Article and Find Full Text PDFJ Manag Care Spec Pharm
January 2025
Global Value and Real-World Evidence, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ.
Background: Bipolar disorder is a severe recurrent, episodic psychiatric condition with a worldwide prevalence of approximately 1%, affecting more than 5 million adults in the United States in 2020. A subtype, bipolar I disorder (BP-I), which accounts for approximately one-quarter of cases, is associated with impairments in psychosocial functioning and quality of life. Recommended treatment options include daily oral, or long-acting injectable, antipsychotics, including the aripiprazole once every month formulation, which has been shown to improve adherence compared with oral treatments.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!